new glp 1 agonist Trends in the Development of GLP-1 Receptor Agonists Glucagon-like peptide-1 receptor: mechanisms and

Endocrinology 156, 28702882

Common side effects include, but may not be limited to: _ pain or redness at the injection site mild diarrhea itching feeling of flushing or swelling all over the body nausea headache drowsiness mild numbness or tingling Serious side effects may include: signs of an allergic reaction difficulty with balance or coordination decreased sense of touch For a comprehensive understanding of all potential side effects, consult a medical professional

Its about matching size to need, not always going bigger

WADA lists IGF-1 and all its analogs, including IGF-1 LR3, on the Prohibited List under peptide hormones, growth factors, related substances, and mimetics (class S2)